Clene (FRA:84C0) Valuation Rank


FRA:84C0 Clene Inc FRA:84C0
27 GF Score
Price €5.20
GF Value €0.77
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clene Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Clene Valuation Rank Related Terms

FRA:84C0
27GF Score
Clene Inc FRA:84C0
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clene (FRA:84C0) Overvalued in 2026?

Based on GuruFocus' analysis, Clene stock appears to be overvalued. The current stock price of €5.20 is trading 575.3% above its estimated GF Value™ of €0.77. GuruFocus considers Clene to be Significantly Overvalued.

Key valuation signals for FRA:84C0:

  • Valuation Rank:
  • GF Value™: €0.77 vs. price of €5.20 (575.3% above fair value)
  • GF Score™: 27/100 with 9 warning signs

No single metric tells the full story. See the FRA:84C0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clene Business Description

Other Exchanges CLNN:USA
Address 6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
27GF Score

Get the complete analysis for FRA:84C0

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.20
Price
€0.77
GF Value